Your browser doesn't support javascript.
loading
Apaf1 nanoLuc biosensors identified lentinan as a potent synergizer of cisplatin in targeting hepatocellular carcinoma cells.
Wang, Zhixin; Qu, Kai; Zhou, Lei; Ren, Li; Ren, Bin; Meng, Fandi; Yu, Wenhao; Wang, Haijiu; Fan, Haining.
  • Wang Z; Department of Hepatopancreatobiliary Surgery, Affiliated Hospital of Qinghai University, China.
  • Qu K; Department of Hepatobiliary Surgery, First Affiliated Hospital of Xi 'an Jiaotong University, China.
  • Zhou L; Department of Hepatobiliary Surgery, Binzhou Medical University Hospital, China.
  • Ren L; Department of Hepatopancreatobiliary Surgery, Affiliated Hospital of Qinghai University, China.
  • Ren B; Department of Hepatopancreatobiliary Surgery, Affiliated Hospital of Qinghai University, China.
  • Meng F; Department of Hepatobiliary Surgery, First Affiliated Hospital of Xi 'an Jiaotong University, China.
  • Yu W; Department of Hepatopancreatobiliary Surgery, Affiliated Hospital of Qinghai University, China.
  • Wang H; Department of Hepatopancreatobiliary Surgery, Affiliated Hospital of Qinghai University, China.
  • Fan H; Department of Hepatopancreatobiliary Surgery, Affiliated Hospital of Qinghai University, China. Electronic address: hainingfan78@gmail.com.
Biochem Biophys Res Commun ; 577: 45-51, 2021 11 05.
Article en En | MEDLINE | ID: mdl-34507064

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Técnicas Biosensibles / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Hepatocelular / Factor Apoptótico 1 Activador de Proteasas / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Técnicas Biosensibles / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Hepatocelular / Factor Apoptótico 1 Activador de Proteasas / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article